Esmolol (Brevibloc)

Ultra-short-acting beta-1-selective (cardioselective) adrenergic antagonist

Esmolol (Brevibloc)

Forms and strengths
Form: TabletStrength: 10 mg/mL (100 mg/10 mL vial; 2500 mg/250 mL premixed bag)
Print

Indication

  • Rapid control of ventricular rate in atrial fibrillation or atrial flutter in acute situations when a short-acting agent is preferred.
  • Management of postintubation tachycardia and hypertension, and other acute perioperative tachycardia where rapid, easily titratable, easily reversible beta-blockade is needed.
  • Used as a second-line acute agent for regular narrow-complex supraventricular tachycardia (AVNRT/AVRT) when adenosine has failed, is contraindicated, or symptoms recur after transient termination, particularly when an IV beta-blocker is preferred over an IV calcium channel blocker (e.g., borderline blood pressure, need for a rapidly reversible agent).
  • For short-term use only (up to 24 hours); not indicated for chronic use.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.